Uvelin Arsen, Hajduković Danica, Vrsajkov Vladimir, Kolak Radmila, Lazukić Aleksandra, Vicković Sanja, Gojković Zoran
Acta Clin Croat. 2013 Dec;52(4):515-22.
We report a case of a patient with acute pancreatitis who developed serious heart rhythm abnormalities on three occasions, two of which were associated with administration of the first generation antihistamine chloropyramine, and the third one with hypomagnesemia and hypokalemia. Dysrhythmic events consisted of bigeminy, multifocal ventricular extrasystoles and torsades de pointes-like ventricular tachycardia. Electrocardiographic changes in acute pancreatitis in the absence of previous heart disease can occur in more than half of the cases. Antihistamines are medications that are known to produce heart rhythm disturbances, especially the second generation drugs astemizole and terfenadine. This is the first report of chloropyramine causing dysrhythmia. It seems that acute pancreatitis patients are especially prone to heart dysrhythmia caused by different factors such as electrolyte disturbances and pronounced vagal tone. Acute pancreatitis may be added to the list of risk factors with altered 'repolarization reserve', predisposing to drug-induced QT interval prolongation and possible torsades de pointes occurrence.
我们报告了一例急性胰腺炎患者,该患者三次出现严重的心律异常,其中两次与第一代抗组胺药氯吡拉敏的使用有关,第三次与低镁血症和低钾血症有关。心律失常事件包括二联律、多灶性室性早搏和尖端扭转型室性心动过速。在既往无心脏病的急性胰腺炎患者中,超过半数会出现心电图改变。抗组胺药是已知会引起心律紊乱的药物,尤其是第二代药物阿司咪唑和特非那定。这是氯吡拉敏引起心律失常的首例报告。似乎急性胰腺炎患者特别容易因电解质紊乱和明显的迷走神经张力等不同因素而发生心律失常。急性胰腺炎可能会被列入具有改变的“复极储备”的危险因素清单中,易导致药物性QT间期延长和可能发生尖端扭转型室速。